Mastorino, L.; Siliquini, N.; Avallone, G.; Ortoncelli, M.; Quaglino, P.; Dapavo, P.; Ribero, S. Seven Cancer Patients Receiving Guselkumab for Treatment of Moderate-to-Severe Psoriasis. Dermatol Reports 2022, 14.